Bolt BiotherapeuticsBOLT
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 21 institutions reported holding Bolt Biotherapeutics Inc. (BOLT) in their 13F filings, down 3 from Q3 2025. 1 opened new positions and 6 sold out. The largest holders were Sofinnova Investments, Inc. ($753K), Pivotal bioVenture Partners Investment Advisor LLC ($517K) and Vivo Capital, LLC ($396K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Bolt Biotherapeutics Inc.
- CUSIP
- 097702203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 6 | $849K |
All 13F filers, Q3 2025 → Q4 2025: 27,902 shares bought and 287,900 shares sold, net −259,998 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Sofinnova Investments, Inc. | 0.03% | No change | 137,721 | $753K |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.20% | No change | 94,573 | $517K |
| Vivo Capital, LLC | 0.03% | Reduce -58.9% | 72,414 | $396K |
| Nan Fung Group Holdings Ltd | 0.29% | No change | 58,347 | $319K |
| Renaissance Technologies | 0.00% | Add +92.2% | 55,025 | $301K |
| T3 Companies, LLC | 0.27% | — | 38,000 | $208K |
| Board of Trustees of The Leland Stanford Junior University | 0.04% | Reduce 0.0% | 35,977 | $197K |
| Pfizer Inc | 0.07% | No change | 31,305 | $171K |
| Nano Cap New Millennium Growth Fund L P | 0.10% | — | 20,500 | $112K |
| Geode Capital Management, LLC | 0.00% | Add +1.5% | 18,803 | $103K |
| Shay Capital LLC | 0.01% | Reduce -4.3% | 15,272 | $84K |
| Vanguard Group Inc. | 0.00% | Reduce -70.3% | 10,179 | $56K |
| BlackRock, Inc. | 0.00% | No change | 9,711 | $53K |
| Morgan Stanley | 0.00% | No change | 3,128 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +179.2% | 723 | $4K |
| UBS Group AG | 0.00% | Add +17066.7% | 515 | $3K |
| Citigroup Inc. | 0.00% | New | 256 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 42 | $230 |
| Bank of America Corp. | 0.00% | No change | 31 | $169 |
| SBI Securities Co., Ltd. | 0.00% | No change | 10 | $55 |
| Barclays PLC | 0.00% | No change | 6 | $33 |
"% of holder's portfolio" is BOLT's weight in each manager's 13F, not the share of Bolt Biotherapeutics Inc. the manager owns.